Page 10 - United Biosource News Today : Breaking News, Live Updates & Top Stories | Vimarsana

UBC Virtual Assistant, Linda, Demonstrates Improvement in Patient Engagement and Therapy Adherence in Patient Support Programs News provided by Share this article Share this article BLUE BELL, Pa., Jan. 22, 2021 /PRNewswire/ -- UBC, a leading global late-stage and patient support services provider, has introduced UBC Pathways® Engage – a virtual patient engagement platform featuring a digital concierge named Linda, designed to create meaningful and long-lasting relationships. UBC's library of intelligent and automated conversation journeys under UBC Pathways®, the company's comprehensiv...

01.13.21 -- #NoGoingBack Supports Keeping Patients First   The Business Of Biotech Cell & Gene Miniseries opens with Dr. Carsten Brunn, president and CEO of Selecta Biosciences. Guest host Erin Harris joins our discussion on Selecta's ImmTOR platform and how the company is addressing the immunogenicity of adeno-associated virus (AAV) vectors challenge faced by gene therapy companies. Listen now and subscribe so you never miss an episode. Featured Editorial By Ed Miseta, chief editor, Clinical Leader #NoGoingBack has been gaining a lot of attention of late. ...

12.23.20 -- Janssen's Patient-centric Approach To Psychiatric Disease Management   On  The Business Of Biotech, AGTC CEO Sue Washer gives a behind-the-scenes look at the creative measures her company took to serve a geographically dispersed clinical patient population and ensure her company met clinical milestones during the COVID-19 pandemic. Listen now and subscribe so you never miss an episode. Focus On Patients By Srihari Gopal, senior director, head of development, psychiatry, Janssen Research & Development Diseases as complex as those of the brain req...

ADVERTISEMENT ADVERTISEMENT Express Scripts Says Bad Jury Instructions Led To $82M Loss Law360 (December 16, 2020, 7:40 PM EST) -- Express Scripts Inc. told the Delaware Supreme Court on Wednesday it should vacate a jury decision that ordered it to pay a Parthenon Capital Partners subsidiary $82 million in damages in a fraudulent inducement case, asserting that the jury was improperly instructed and a new trial is warranted. During virtual oral arguments in front of the full slate of justices, counsel for Express Scripts said a flawed instruction given to a Superior Court jury tainted its Ju...